What is the most appropriate analgesic for a patient who is allergic to codeine?

Best Pain Medication for Codeine Allergy

For patients with codeine allergy, NSAIDs (ibuprofen 400-600 mg or naproxen) are the first-line choice for mild-to-moderate pain, while oxycodone-acetaminophen or hydromorphone are preferred over codeine-containing products for moderate-to-severe pain requiring opioid therapy. 1

Pain Severity-Based Algorithm

Mild-to-Moderate Pain (NRS 1-6)

NSAIDs are superior to codeine-containing products and should be used first-line:

• Ibuprofen 400 mg has a number needed to treat (NNT) of 2.7 compared to 4.4 for codeine-acetaminophen 1
• NSAIDs provide longer time to re-medication with a safer side effect profile (NNT of 6 for codeine-acetaminophen) 1
• NSAIDs lack the CNS depressing effects of codeine and avoid the genetic variability problem where certain CYP2D6 polymorphisms cause unpredictable metabolism of codeine to morphine 1
• COX-2 specific NSAIDs (celecoxib 400 mg) have an NNT of 2.5 versus 3.9 for acetaminophen-codeine, with average time to re-medication of 8.4 hours versus 4.1 hours 1

If opioids are required:

• Oxycodone-acetaminophen is marginally superior to codeine-acetaminophen based on Cochrane reviews 1
• Tramadol should be avoided as it is a prodrug with poor efficacy compared to morphine, has dose titration limitations due to neurotoxicity threshold, and has multiple drug interactions 2, 3

Moderate-to-Severe Pain (NRS 7-10)

For parenteral administration:

• Fentanyl (1 mcg/kg, then ~30 mcg q 5 min) is recommended over morphine 1
• Fentanyl has shorter onset of action, is 100 times more potent than morphine, and critically, patients with morphine allergies do not have allergies to fentanyl 1
• Hydromorphone (0.015 mg/kg IV) is comparable and potentially superior to morphine (0.1 mg/kg IV) with quicker onset of action 1
• Hydromorphone causes little or no histamine release and may be safely administered to patients with type 2 allergy to morphine (urticaria, pruritus, facial flushing) 1

For oral administration:

• Oral morphine remains the opioid of first choice for moderate-to-severe cancer pain 4, 5
• Hydromorphone or oxycodone (immediate release forms) are appropriate alternatives 1
• Low-dose strong opioids in combination with non-opioid analgesics are preferred over weak opioids like codeine 5, 2

Critical Caveats

Codeine-specific concerns that justify avoidance:

• Codeine is a prodrug requiring CYP2D6 metabolism to morphine for analgesic effect 6, 2
• Genetic polymorphisms (more common in Asians) result in poor metabolizers with inadequate analgesia or ultra-rapid metabolizers with toxicity risk 1, 2
• Codeine has demonstrated poor efficacy in randomized controlled trials, with the poorest analgesic effect among commonly used analgesics in acute postoperative pain 3, 7
• Drugs that inhibit CYP2D6 reduce codeine's analgesic effects 6, 2

Renal impairment considerations:

• Avoid codeine, morphine, and meperidine in renal insufficiency (GFR <30 mL/min/1.73 m²) due to active metabolite accumulation 6
• Fentanyl and buprenorphine (transdermal or IV) are the safest opioids in chronic kidney disease stages 4-5 4
• Use hydrocodone, oxycodone, and hydromorphone with caution and dose adjustment in renal insufficiency 6

Cross-reactivity warning:

• True IgE-mediated codeine allergy is rare but documented 8
• If the allergy is actually a morphine allergy misattributed to codeine, hydromorphone may be safely used for type 2 reactions (non-IgE mediated histamine release) 1
• Fentanyl has no cross-reactivity with morphine allergies 1